ACIP releases the 2017 adult and childhood immunization schedules

United States of America
NITAGs
6 February 2017

The CDC and its Advisory Committee on Immunization Practices (ACIP), together with the AAFP and other medical professional organizations, have released the 2017 adult and childhood immunization schedules.

visitor_center.jpg

Changes this year include updated recommendations for a two-dose schedule of nine-valent HPV vaccine (HPV9; Gardasil 9) for patients ages 11-12, a two-dose schedule of meningitis B vaccine (MenB) for adolescents, a clarification regarding recommended adult candidates for hepatitis B (HepB) vaccine and revisions designed to make the adult schedule easier to navigate.

Release of the annual immunization schedules comes amid concerns that the Trump administration has proposed appointing a group to study the safety and effectiveness of vaccines.
In response, AAFP President John Meigs, M.D., of Centreville, Ala., said in a statement: "A new federal commission on immunizations is not necessary and would divert much-needed dollars from other, more pressing health care issues. To suggest the need for such an organization promotes unnecessary, ongoing and disproven skepticism about vaccines and public safety."

Meigs said plainly that vaccines are safe, effective and save lives, further explaining that allegations of a link between vaccines and autism have been thoroughly debunked.
"The science is clear, and family physicians stand ready to help everyone -- from the incoming administration to the general public -- understand how safe and important vaccines are," he stated.

Related News & Events

  • WHO China
    Beijing, P.R. China
  • Kazakhstan
    NITAGs

    Voice from the field : Lyazzat Yeraliyeva

    14.11.2017

    The NITAG of Kazakhstan recently launched their website to make their recommendations available and promote the work of the members. Lyazzat Yeraliyeva, former Chair of the NITAG, now acts as the Deputy Chair.

    Read more
  • NITAGs

    Strenghtening NITAGs through the Partnership for Influenza Vaccine Introduction

    07.11.2017

    The Partnership for Influenza Vaccine Introduction (PIVI), based at The Task Force for Global Health (TFGH), is an innovative public/private program that partners with the Centers for Disease Control and Prevention (CDC), Ministries of Health, corporate partners and others to create sustainable, routine, seasonal influenza vaccination programs in low- and middle-income countries.   PIVI’s goal is to create routine, seasonal influenza vaccination programs to protect communities from the impacts of both seasonal and pandemic influenza. Working with countries’ Ministries of Health, as well as with other technical collaborators, PIVI supports capacity building for NITAGs to make evidence-based vaccine policy decision making.  These activities are coordinated with NITAG strengthening work carried out through other projects and cooperative funding agreements between countries and CDC’s Influenza and Global Immunization Divisions.  The work is also closely coordinated with NITAG focal points in WHO regional and country offices.  

    Read more